SCCM
NVO

Schafer Cullen Capital Management’s Novo Nordisk NVO Stock Holding History

Schafer Cullen Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-488,320
Closed -$11.5M – 249
2018
Q3 		$11.5M Sell
488,320
-20,000
-4% -$488K 0.15% 91
2018
Q2 		$11.7M Sell
508,320
-80,880
-14% -$1.92M 0.15% 91
2018
Q1 		$14.5M Sell
589,200
-34,940
-6% -$917K 0.17% 89
2017
Q4 		$16.7M Sell
624,140
-53,920
-8% -$1.37M 0.19% 86
2017
Q3 		$16.3M Buy
+678,060
New +$15.3M 0.2% 85

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Schafer Cullen Capital Management's NVO Position: Q4 2018 in Review

Schafer Cullen Capital Management sold out of Novo Nordisk (NVO) in Q4 2018, closing a stake of 488,320 shares — an estimated $11.5M sold.

Schafer Cullen Capital Management first reported a position in NVO in Q3 2017 and held it in 5 quarters. The position peaked at $16.7M in Q4 2017. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.

  • Schafer Cullen Capital Management reported no remaining Novo Nordisk position as of Q4 2018 after selling out during the quarter.
  • Schafer Cullen Capital Management sold 488,320 Novo Nordisk shares in Q4 2018, an estimated $11.5M.
  • Schafer Cullen Capital Management first reported a position in Novo Nordisk in Q3 2017 and held it in 5 quarters.
  • Schafer Cullen Capital Management's Novo Nordisk position peaked at $16.7M in Q4 2017.
  • 550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.

Based on Schafer Cullen Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.